Oncology Ultrasound

The portable ATUSA™ System reportedly provides 3D ultrasound visualization of the entire breast volume in two minutes.

A new study suggests that deep learning algorithms with multimodal ultrasound have comparable specificity and sensitivity to subjective expert assessment and use of the O-RADS classification to distinguish between benign and malignant ovarian tumors.

Validating a prognostic scoring system for locoregional recurrence risk in post-mastectomy patients with varying levels of axillary lymph node involvement, emerging research suggests patients with intermediate risk for breast cancer recurrence could benefit from post-mastectomy radiotherapy.

What is your diagnosis?

Distinguishing between classic and non-classic presentations of isolated adnexal lesions on pelvic ultrasound reportedly had a high specificity and sensitivity in diagnosing ovarian cancer in women at average risk.

In combination with cloud-based data infrastructure and artificial intelligence (AI) applications, handheld ultrasound devices may have the potential to significantly enhance efficiency for providers and contribute to improved patient outcomes.

Emerging research suggests that mammograms should not be delayed for women who develop unilateral lymphadenopathy after receiving COVID-19 vaccines, and that follow-up imaging is unnecessary for patients who have no history of cancer or suspicious concurrent symptoms.

The iBreastExam, a handheld device cleared by the FDA, reportedly enhances routine clinical breast examinations.

Will this artificial intelligence technology improve diagnostic accuracy and reduce false positive biopsy orders?

Breast ultrasound/MRI fusion significantly improves localization of incidentally detected MRI lesions which are occult on an initial ultrasound survey alone.

Investigators at Massachusetts General Hospital proposed an algorithm for appropriate axillary nodal imaging to better align with changes in treatment algorithms for axillary nodal disease in patients with breast cancer.

Position statement supports radiofrequency ablation, cryoablation, and microwave ablation as appropriate image-guided treatment options.

Non-invasive test misses more than four times the number of endometrial cancer cases in Black women than with white counterparts.

Take a quick look at Diagnostic Imaging's Top 5 stories of the week.

Undergoing more frequent abdominal screening can improve life expectancy and quality of life for patients with hepatocellular carcinoma.

No difference was seen between women who were screened yearly and those who did not undergo annual exams.

Algorithms outperformed providers in accurate, quick detection and classification.

Advanced technology solutions are key to helping providers detect colorectal cancer faster and sooner.

Cherenkov imaging uses special BeamSite cameras to capture radiation beam interaction with tissue, making radiation oncology treatments a visual process.

Clinical trial results show MRI as more accurate and less intrusive at diagnosis for men with a clinical suspicion of prostate cancer.

Men with intermediate-risk prostate cancer can be successfully treated with MRI-guided high-intensity focused ultrasound without experiencing incontinence or erectile dysfunction.

Here's what to expect this week on Diagnostic Imaging.

Seno’s Imagio® breast imaging system can help providers distinguish, in real-time, between benign and malignant breast lesions.

Pairing MR-guided high intensity focused ultrasound with the standard-of-care, external beam radiotherapy, can offer faster pain relief to patients.

Here's what to expect this week on Diagnostic Imaging.

Five-year contract furthers the companies’ existing partnership.

Popping microbubbles with ultrasound waves prompts greater radiation susceptibility, leading to lower tumor growth and better long-term patient outcomes.

Here's what to expect this week on Diagnostic Imaging.

Here's what to expect this week on Diagnostic Imaging.

Research indicates patients who undergo a single 28-Gy session experience similar outcomes to those who have four 12-Gy sessions, pointing to safer, faster treatment.